Enovix Corporation (NASDAQ:ENVX - Get Free Report) was the target of some unusual options trading on Friday. Investors purchased 24,908 call options on the stock. This is an increase of approximately 104% compared to the typical volume of 12,237 call options.
Hedge Funds Weigh In On Enovix
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Sax Wealth Advisors LLC bought a new stake in shares of Enovix during the 3rd quarter worth approximately $29,000. Caitong International Asset Management Co. Ltd acquired a new position in Enovix during the fourth quarter valued at approximately $30,000. Calamos Advisors LLC acquired a new position in Enovix during the first quarter valued at approximately $60,000. Sequoia Financial Advisors LLC bought a new stake in Enovix during the second quarter worth $61,000. Finally, Gateway Wealth Partners LLC bought a new stake in shares of Enovix during the 1st quarter worth $68,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Price Performance
Enovix stock traded up $0.24 during mid-day trading on Friday, reaching $2.79. 7,721,112 shares of the company were exchanged, compared to its average volume of 6,859,975. The firm has a market cap of $613.36 million, a PE ratio of -3.45 and a beta of 2.49. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The company has a fifty day simple moving average of $3.00 and a 200-day simple moving average of $4.94. Enovix has a 12 month low of $2.20 and a 12 month high of $12.65.
Enovix (NASDAQ:ENVX - Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The firm had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The company's revenue was up 20.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. As a group, equities research analysts expect that Enovix will post -0.79 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
ENVX has been the topic of a number of recent research reports. William Blair lowered Enovix from an "outperform" rating to a "market perform" rating in a research note on Monday, August 17th. TD Cowen upgraded Enovix to a "hold" rating in a research note on Monday, October 5th. Craig Hallum set a $7.00 price objective on Enovix in a report on Thursday, August 13th. Loop Capital upgraded Enovix to a "strong-buy" rating in a research report on Monday, August 17th. Finally, B. Riley Financial dropped their target price on Enovix from $10.00 to $9.00 and set a "buy" rating for the company in a report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Enovix currently has an average rating of "Moderate Buy" and a consensus price target of $10.77.
Check Out Our Latest Stock Analysis on Enovix
About Enovix
(
Get Free Report)
Enovix Corporation is a battery technology company that develops lithium-ion batteries using a silicon-anode architecture. Its approach is designed to increase energy density while maintaining safety and cycle-life characteristics through a three-dimensional cell design and a mechanical constraint system that helps manage silicon expansion during charging.
The company's products are intended for applications that require compact, high-performance power sources, including consumer electronics, wearable devices, Internet of Things equipment, industrial products, and defense and aerospace systems.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.